Retraction of: Apigenin inhibits growth and migration of fibroblasts by suppressing FAK signaling
Hongyi Wang, Bingyu Guo, Shixiu Lin, Peng Chang, Kai Tao

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsNatural Compounds in Disease Treatment · Protease and Inhibitor Mechanisms · Bone Metabolism and Diseases
This article has been retracted: Aging has completed its investigation of this paper. We found multiple instances of image reuse and overlap with images from unrelated papers from different institutions. Specifically:
Figure 1:
The transwell assay image in Figure 1G is a reuse of image in Figure 4G from the authors earlier paper [1];
The control transwell assay image in Figure 1H was reused in Figure 2G of the authors 2021 paper [2], which is already retracted;
The control transwell assay image in Figure 1H overlaps with an unrelated image in Figure 5D from already retracted paper [3];
The images in Figure 1H, 1I overlap with the images in Figure 5B from earlier published unrelated paper [4];
Also, images in Figure 1I overlap with the images in Figures 4A and 5B from already retracted paper [5];
Additionally, the images in Figure 1I were found in Figure 3F from concurrently published paper [6].
Figure 4:
The transwell assay images in Figure 4A, 4B were found to overlap with images in Figure 4F of [1], Figure 4C of [4], Figure 4D of [5], and Figure 3C from [6].
The corresponding author informed us that these overlaps were due to improper data storage in the laboratory and has applied for a retraction. Given these findings, the Editorial decision was to retract the paper. All authors have agreed to this retraction.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Song Y, Guo B, Ma S, Chang P, Tao K. Naringin suppresses the growth and motility of hypertrophic scar fibroblasts by inhibiting the kinase activity of Akt. Biomed Pharmacother. 2018; 105:1291–8. 10.1016/j.biopha.2018.06.10330021366 · doi ↗ · pubmed ↗
- 2Xu Y, Guo B, Liu X, Tao K. mi R-34a inhibits melanoma growth by targeting ZEB 1. Aging (Albany NY). 2021; 13:15538–47. 10.18632/aging.203114 Retraction in: Aging. 2024; 16:13432. DOI: 10.18632/aging.206155 PMID 3962255934102608 PMC 8221330 · doi ↗ · pubmed ↗
- 3Shan L, Liu W, Zhan Y. Sulfated polysaccharide of Sepiella maindroni ink targets Akt and overcomes resistance to the FGFR inhibitor AZD 4547 in bladder cancer. Aging (Albany NY). 2019; 11:7780–95. 10.18632/aging.102286 Retraction in: Aging. 2024; 16:12562. DOI: 10.18632/aging.206104 PMID 3934848931545294 PMC 6782013 · doi ↗ · pubmed ↗
- 4Jiashi W, Chuang Q, Zhenjun Z, Guangbin W, Bin L, Ming H. Micro RNA-506-3p inhibits osteosarcoma cell proliferation and metastasis by suppressing RAB 3D expression. Aging (Albany NY). 2018; 10:1294–305. 10.18632/aging.10146829905536 PMC 6046236 · doi ↗ · pubmed ↗
- 5He M, Shen P, Qiu C, Wang J. mi R-627-3p inhibits osteosarcoma cell proliferation and metastasis by targeting PTN. Aging (Albany NY). 2019; 11:5744–56. 10.18632/aging.102157 Retraction in: Aging. 2024; 16:12953. DOI: 10.18632/aging.206128 PMID 3940520331413208 PMC 6710034 · doi ↗ · pubmed ↗
- 6Chen J, Yan C, Yu H, Zhen S, Yuan Q. mi R-548d-3p inhibits osteosarcoma by downregulating KRAS. Aging (Albany NY). 2019; 11:5058–69. 10.18632/aging.10209731327761 PMC 6682526 · doi ↗ · pubmed ↗
